Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.3K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.3K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

434
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
434
Cancer Vaccines01:30

Cancer Vaccines

468
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
468
Cancer02:18

Cancer

49.0K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.0K
Cancer Prevention02:59

Cancer Prevention

6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.2K
Prevalence and Incidence01:08

Prevalence and Incidence

678
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
678

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer pattern in Bhutan (2014-2022): Findings from population-based cancer registry-A pathway to monitor cancer control activities.

International journal of cancer·2026
Same author

Lung Cancer Sessions in Annual Conferences: Need for Better Interactions and Collaboration between Oncologists and Pulmonologists.

South Asian journal of cancer·2025
Same author

Haploidentical Hematopoietic Cell Transplants in India.

South Asian journal of cancer·2025
Same author

Setting Up Geriatric Oncology Clinical Services: Asian Geriatric Oncology Society Guidelines 2025 (Part 1).

South Asian journal of cancer·2025
Same author

Consensus Statements for Clinical Practice in Advanced/Metastatic Colorectal Cancers in India Using a Modified Delphi Method.

South Asian journal of cancer·2025
Same author

Novel Nomogram for Prediction of Lymph Node Metastases from Buccal Mucosa Squamous Carcinoma Using Histological Parameters.

South Asian journal of cancer·2025
Same journal

Corrigendum: Long-Term Outcomes of Thymoma Treated at a Single Institute.

South Asian journal of cancer·2026
Same journal

Spindle Cell Variant of Rhabdomyosarcoma: An Aggressive Clinical Case of the Oral Cavity.

South Asian journal of cancer·2025
Same journal

Safety and Efficacy of Alectinib in the First Line for ALK-Mutated Lung Cancer: A Real-World Data from India.

South Asian journal of cancer·2025
Same journal

Retrospective Outcome Analysis of Allogenic Bone Graft.

South Asian journal of cancer·2025
Same journal

Real-World Experience of First-Line Osimertinib in EGFR Mutated Non-Small Cell Lung Cancers from a Tertiary Cancer Center, India.

South Asian journal of cancer·2025
Same journal

Comparative Analysis of Surgical Site Infections in Pediatric Brain Tumor Patients: Hygiene Practices, Risk Factors, and Implications for Healthcare Costs and Mortality.

South Asian journal of cancer·2025
See all related articles

Related Experiment Video

Updated: Aug 8, 2025

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.5K

Cervical Cancer in SAARC Countries.

Purvish M Parikh1, Sujith Kumar Mullapally2, Sachin Hingmire3

  • 1Department of Clinical Hematology, Mahatma Gandhi University of Health Sciences and Technology, Jaipur, Rajasthan, India.

South Asian Journal of Cancer
|February 28, 2023
PubMed
Summary
This summary is machine-generated.

Cervical cancer screening and HPV vaccination strategies vary across SAARC nations. While some countries aim for WHO targets, resource limitations and cost impact widespread implementation of effective prevention programs.

Keywords:
HPVLMICscreeningvaccination

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

318
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

27.5K

Related Experiment Videos

Last Updated: Aug 8, 2025

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.5K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

318
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

27.5K

Area of Science:

  • Public Health
  • Oncology
  • Global Health

Background:

  • Cervical cancer remains a significant global health burden, disproportionately affecting low- and middle-income countries (LMICs).
  • Despite global incidence reduction efforts, the absolute number of cervical cancer cases continues to rise.
  • The SAARC region faces unique challenges in cervical cancer control.

Purpose of the Study:

  • To assess current cervical cancer screening and vaccination practices in SAARC countries.
  • To identify challenges and potential solutions for cervical cancer control programs in the region.
  • To gauge perceptions on achieving World Health Assembly targets for cervical cancer elimination.

Main Methods:

  • A 21-question multiple-choice online survey was conducted in January 2023.
  • The survey targeted 9 SAARC countries, receiving 367 responses.
  • Data analysis focused on representative answers from each participating country.

Main Results:

  • Only Bhutan and Nepal expressed confidence in meeting World Health Assembly targets.
  • Screening recommendations varied, with most countries advocating for asymptomatic patient screening.
  • Preferred screening strategies included visual inspection with acetic acid/lugol's iodine (VIA/VILI), HPV DNA testing plus cytology, and a screen-triage-treat approach.
  • HPV vaccination was recommended for girls aged 10-26, contingent on vaccine affordability.

Conclusions:

  • The survey highlights significant challenges in cervical cancer control within SAARC countries.
  • Consensus exists on potential solutions for both public and private cervical cancer programs.
  • Implementing cost-effective HPV vaccination and tailored screening strategies are crucial for progress.